Pfizer, DxS enter pact to develop companion diagnostic test kit for brain tumour patients
Saturday, February 06, 2010 11:00 IST Manchester, England
Pfizer Inc. and DxS (a wholly owned subsidiary of Qiagen N.V.) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110)